The role of phosphodiesterase 3 in endotoxin-induced acute kidney injury

被引:10
作者
Choi, Won-Il [1 ,2 ,3 ,4 ,5 ]
Kwon, Kun Young [4 ,5 ,6 ]
Seo, Jeong Wook [7 ]
Beagle, John [1 ,2 ]
Quinn, Deborah A. [1 ,2 ]
Hales, Charles A. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Pulm Crit Care Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Keimyung Univ, Sch Med, Dongsan Hosp, Dept Internal Med,Pulm Unit, Taegu, South Korea
[4] Keimyung Univ, Sch Med, Taegu, South Korea
[5] Keimyung Univ, Inst Med Genet, Taegu, South Korea
[6] Keimyung Univ, Sch Med, Dongsan Hosp, Dept Pathol, Taegu, South Korea
[7] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul Natl Univ Hosp, Seoul 151, South Korea
关键词
ACUTE-RENAL-FAILURE; NITRIC-OXIDE SYNTHASE; PROXIMAL TUBULE INJURY; ISCHEMIA/REPERFUSION INJURY; CELL INJURY; RAT; LIPOPOLYSACCHARIDE; CAMP; INHIBITION; MECHANISMS;
D O I
10.1186/1471-2334-9-80
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Acute kidney injury frequently accompanies sepsis. Endotoxin is known to reduce tissue levels of cAMP and low levels of cAMP have been associated with renal injury. We, therefore, hypothesized that endotoxin induced renal injury by activating phosphodiesterase 3 (PDE3) which metabolizes cAMP and that amrinone an inhibitor of PDE3 would prevent the renal injury. Methods: Animals were divided into three groups (n = 7/group): 1) Control (0.9% NaCl infusion without LPS); 2) LPS (0.9% NaCl infusion with LPS); 3) Amrinone+LPS (Amrinone infusion with LPS). Either lipopolysaccharide (LPS) or vehicle was injected via the jugular vein and the rats followed for 3 hours. We explored the expression of PDE3 isoenzymes and the concentrations of cAMP in the tissue. Results: The PDE3B gene but not PDE3A was upregulated in the kidney of LPS group. Immunohistochemistry also showed that PDE3B was expressed in the distal tubule in the controls and LPS caused PDE3B expression in the proximal as well. However, PDE3A was not expressed in the kidney either in the control or LPS treated groups. Tissue level of cAMP was decreased after LPS and was associated with an increase in blood urea nitrogen, creatinine, ultrastructural proximal tubular changes, and expression of inducible nitric oxide synthase (iNOS) in the endotoxemic kidney. In septic animals the phosphodiesterase 3 inhibitor, amrinone, preserved the tissue cAMP level, renal structural changes, and attenuated the increased blood urea nitrogen, creatinine, and iNOS expression in the kidney. Conclusion: These findings suggest a significant role for PDE3B as an important mediator of LPS-induced acute kidney injury.
引用
收藏
页数:10
相关论文
共 47 条
[1]   Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats [J].
Asakura, H ;
Asamura, R ;
Ontachi, Y ;
Hayashi, T ;
Yamazaki, M ;
Morishita, E ;
Miyamoto, KI ;
Nakao, S .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (05) :1050-1055
[2]   HEMODYNAMIC ASSESSMENT OF AMRINONE - NEW INOTROPIC AGENT [J].
BENOTTI, JR ;
GROSSMAN, W ;
BRAUNWALD, E ;
DAVOLOS, DD ;
ALOUSI, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (25) :1373-1377
[3]   Differential effects of amrinone and milrinone upon myocardial inflammatory signaling [J].
Chanani, NK ;
Cowan, DB ;
Takeuchi, K ;
Poutias, DN ;
Garcia, LM ;
del Nido, PJ ;
McGowan, FX .
CIRCULATION, 2002, 106 (13) :I284-I289
[4]   Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury [J].
Chatterjee, PK ;
Patel, NSA ;
Kvale, EO ;
Cuzzocrea, S ;
Brown, PAJ ;
Stewart, KN ;
Mota-Filipe, H ;
Thiemermann, C .
KIDNEY INTERNATIONAL, 2002, 61 (03) :862-871
[5]   RENAL EFFECTS OF ENDOTOXIN IN THE MALE-RAT [J].
CHURCHILL, PC ;
BIDANI, AK ;
SCHWARTZ, MM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (02) :F244-F250
[6]   DIRECT EFFECTS OF ENDOTOXIN ON THE FUNCTION OF THE ISOLATED PERFUSED RAT-KIDNEY [J].
COHEN, JJ ;
BLACK, AJ ;
WERTHEIM, SJ .
KIDNEY INTERNATIONAL, 1990, 37 (05) :1219-1226
[7]   Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3) [J].
Degerman, E ;
Belfrage, P ;
Manganiello, VC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) :6823-6826
[8]   Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney [J].
Dousa, TP .
KIDNEY INTERNATIONAL, 1999, 55 (01) :29-62
[9]   Reduced phosphodiesterase 3 activity and phosphodiesterase 3A level in synthetic vascular smooth muscle cells: Implications for use of phosphodiesterase 3 inhibitors in cardiovascular tissues [J].
Dunkerley, HA ;
Tilley, DG ;
Palmer, D ;
Liu, HG ;
Jimmo, SL ;
Maurice, DH .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :1033-1040
[10]  
Elenkov IJ, 2000, PHARMACOL REV, V52, P595